Pierre Van Weperen joins Ashfield as MD for Commercial and Patient Solutions
Ashfield, part of UDG Healthcare, an international healthcare services provider, has announced the appointment of Pierre Van Weperen as Commercial and Patient Solutions UK...
The King’s Fund appoints Richard Murray as Chief Executive
Richard Murray, currently Director of Policy at The King’s Fund, has been appointed as its new Chief Executive. He will succeed Professor Sir Chris...
How to get promoted
Liz Walker, HR Director, Unum UK, shares her top tips for getting promoted.
If you’ve been working consistently hard, meeting and exceeding all expectations and...
Chris McCourt: Mentors, motivation and women in pharma
As Chris McCourt, Global Sales Excellence Lead, Respiratory, AstraZeneca, celebrates three decades in industry, we ask her about mentors, motivation, and encouraging more women...
Vertex appoints Ludovic Fenaux as Senior Vice President, International Commercial Operations
Vertex Pharmaceuticals Incorporated has announced that Ludovic Fenaux has been appointed Senior Vice President, International Commercial Operations with responsibility for commercial activities outside of...
Mover & Shaker of the month: Troy Robinson
Troy Robinson, Managing Director, Chugai Pharma UK, on how creativity and innovation are key to success.
I love my job because…
I love my job because... Catherine Williams, Diabetes and Cardiovascular Business Unit Director, MSD in the UK, joint winner of the Cross-Functional Team Pf Award 2018.
MSD’s ‘What gets me out of bed in the morning?’ campaign can be found at msd-uk.com
Star retains Gold standard IIP accreditation
Star is delighted to announce that they have retained their Gold standard Investors In People accreditation. Investors In People (IIP) work with organisations globally who...
Medmeme appoints senior strategist Dr Christian Schweiger
Christian Schweiger, MD, PhD, has been appointed Vice President for Medical Affairs Strategy, Europe, at Medmeme, which is home to the world’s most comprehensive,...
Novartis appoint Dr. Klaus Moosmayer as Chief Ethics, Risk & Compliance Officer
Novartis has announced the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO...
Latest articles
Maxwellia expand their team with two new appointments
Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.
BMS & Boston Medical Center announce research collaboration
BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
EC approves KEYTRUDA® as adjuvant therapy
MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...